Minimal residual disease (MRD) analysis in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)] by real time PCR (RT-PCR) and flow cytometry (FC).

被引：0
|
作者：
Perea, G
Lasa, A
Aventin, A
Domingo, A
Villamor, N
de Llano, MPQ
Llorente, A
Junca, J
Palacios, C
Fernandez, C
Gilallart, M
Font, L
Tormo, M
Florensa, L
Bargay, J
Marti, JM
Vivancos, P
Torres, P
Berlanga, J
Brunet, S
Sierra, J
Nomdedeu, JF
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Bellvitge Hosp, Hosp Llobregat, Barcelona, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Virgen Victoria, Malaga, Spain
[5] Hosp Joan 23, Tarragona, Spain
[6] Hosp Germans Trias & Pujol, Badalona, Spain
[7] Hosp Gen Valle Hebron, Barcelona, Spain
[8] Hosp Josep Trueta, Girona, Spain
[9] Hosp Arnau Vilanova, Lerida, Spain
[10] Hosp Verge Cinta, Tarragona, Spain
[11] Hosp Clin, Valencia, Spain
[12] Hosp Mer, Barcelona, Spain
[13] Hosp Son Llatzer, Mallorca, Spain
[14] Mutua Terrassa, Barcelona, Spain
[15] Clin Teknon, Barcelona, Spain
[16] Hosp Juan Canalejo, La Coruna, Spain
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2989.2989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2989
引用
收藏
页码：817A / 817A
页数：1
相关论文
共 50 条
  • [41] Complemental roles for multiparameter flow cytomety and quantitative RT-PCR for the quantification of minimal residual disease in patients with acute myeloid leukemia.
    Kern, W
    Schoch, C
    Haferlach, T
    Voskova, D
    Hiddemann, W
    Schnittger, S
    BLOOD, 2003, 102 (11) : 65A - 65A
  • [42] IN ADULT ACUTE MYELOID LEUKEMIA (AML) PERIPHERAL BLOOD MEASURABLE RESIDUAL DISEASE (MRD) BY FLOW CYTOMETRY (FC) IS FEASIBLE AND IS PROGNOSTICALLY RELEVANT
    Maurillo, L.
    Buccisano, F.
    Piciocchi, A.
    Del Principe, M. I.
    Candoni, A.
    Melillo, L.
    Calafiore, V.
    Cairoli, R.
    De Fabritiis, P.
    Storti, G.
    Salutari, P.
    Lanza, F.
    Martinelli, G.
    Luppi, M.
    Mazza, P.
    Martelli, M. P.
    Cuneo, A.
    Albano, F.
    Fabbiano, F.
    Tafuri, A.
    Chierichini, A.
    Tieghi, A.
    Fracchiolla, N. S.
    Capelli, D.
    Foa, R.
    Alati, C.
    La Sala, E.
    Voso, M. T.
    Fazi, P.
    Vignetti, M.
    Consalvo, M. Irno
    Ottone, T.
    Lavorgna, S.
    Arcese, W.
    Lo Coco, F.
    Amadori, S.
    Venditti, A.
    HAEMATOLOGICA, 2019, 104 : 12 - 13
  • [43] Minimal residual disease (MRD) detection of the t(12;21) TEL-AML1 fusion-transcript by quantitative real-time RT-PCR.
    Pallisgaard, N
    Hokland, P
    BLOOD, 1998, 92 (10) : 392A - 392A
  • [44] Quantitative detection of minimal residual disease (MRD) in AML patients by simultaneous amplification of t(8;21) mRNA and a control mRNA by real time quantitative PCR.
    Schüler, F
    Kiefer, T
    Dölken, L
    BLOOD, 1998, 92 (10) : 74A - 74A
  • [45] Detection of BCR-ABL transcripts in chronic myeloid leukemia by real-time RT-PCR: diagnosis and quantitation of minimal residual disease
    Saussoy, P
    Vaerman, JL
    Straetmans, N
    Latinne, D
    LEUKEMIA, 2001, 15 (12) : 2023 - 2024
  • [46] Minimal residual disease (MRD) monitoring with qualitative RT-PCR in chronic myeloid leukemia (CML) patients submitted to allogeneic stem cell transplantation
    Bernasconi, P
    Alessandrino, EP
    Calatroni, S
    Caldera, D
    Colombo, AA
    Malcovati, L
    Varettoni, M
    Cavigliano, PM
    Rocca, B
    Boni, M
    Giardini, I
    Caresana, M
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2002, 29 : S123 - S123
  • [47] Minimal residual disease in patients with acute myeloid leukemia quantified by multiparameter flow cytomety and quantitative RT-PCR is an independent prognostic parameter.
    Kern, W
    Schoch, C
    Haferlach, T
    Voskova, D
    Hiddemann, W
    Schnittger, S
    BLOOD, 2004, 104 (11) : 95A - 95A
  • [48] Real-time PCR for quantitative detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL)
    Pongers-Willemse, MJ
    Verhagen, OJHM
    Tibbe, GJM
    Wijkhuijs, JM
    De Haas, V
    Van Wering, ER
    Van der Schoot, CE
    Van Dongen, JJM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 292 - 292
  • [49] Detection of minimal residual disease (MRD) in APL by "real-time" RT-PCR: Analysis of cases entered into the UK MRC ATRA trial.
    Grimwade, D
    Diverio, D
    Harrison, G
    Wheatley, AK
    Rodgers, J
    Lo Coco, F
    Goldstone, AH
    Solomon, E
    Burnett, AK
    BLOOD, 1999, 94 (10) : 625A - 625A
  • [50] Time point-dependent concordance and prognostic significance of flow cytometry and real time quantitative PCR for measurable/minimal residual disease detection in acute myeloid leukemia with t(8;21)(q22;q22.1)
    Shang, Lei
    Cai, Xiaojin
    Sun, Wanchen
    Cheng, Qingnian
    Mi, Yingchang
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2022, 102 (01) : 34 - 43
12345